Postby Bpaint » Mon Feb 07, 2022 2:22 pm
My husband had his third round of Folfiri + Avastin today, and his CEA has more than doubled since he started. It is now 145, from 60. He had a CEA surge when he started Folfox and when he did Vectibix, but not this high. His oncologist has always told us that he doesn't worry too much about CEA increases unless the number doubles, so this one has me worried. Could it still be part of the initial CEA flare from starting a new treatment?
husband (age 41 at dx):
8/20 CRC Stage 4. Mets to lungs, liver, distant lymph nodes
MSS, KRAS wild
CEA 713 at dx
Folfox (12 rounds)
Liver, colon and node resection 4/21
New lung mets, Vectibix monotherapy started 6/21
Stop Vectibix lungs stable about 6 months; all other areas stable
Start Folfiri + avastin 1/22
Stop Folfiri (lungs stable 6 mos); start Vectibix 7/22
Stop Vectibix 12/22 (lungs stable 5 mos this time)
SBRT on lung Mets scheduled for 1/22, will restart Folfiri